Jayex to sell its on-premises Acute (hospital) queue management business for £1.3M (3.1x
recurring earnings) to Canadian based medical technology company Vitalhub Inc with
completion expected end of April 2021
• Vitalhub to purchase all existing hospital contractsin the UK and Australia from Jayex, including
an Enlighten license to operate the services
• Transaction value of £1.3M (~$2.4M AUD) in cash and Vitalhub shares + additional earn out
capacity of up to £1.0M (~$1.8M AUD)
• Jayex retains all IP and ownership of the Enlighten technology stack
• Divestment enables Jayex to focus on core and higher-margin NHS GP (Primary Care) and
Community markets and increase services offered through its SaaS based Connect platform
• Funds released for the development of NZ based cannabis subsidiary
Now were funded for development of the Medical Marijuana... No cash raise needed this is sounding better by the minute
- Forums
- ASX - By Stock
- Ann: Jayex divests Acute (hospital) queue management business
Jayex to sell its on-premises Acute (hospital) queue management...
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JTL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.406M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
JTL (ASX) Chart |
Day chart unavailable